- Filed
- Dec 2, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Mar 31, 2025 | 14.59M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 12.5M sh |
| Capex | Q2 2025 · Mar 31, 2025 | $238.68K |
| Capex | Q2 2025 · Mar 31, 2024 | $28.78K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2025 | −$2.8M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$1.26M |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $12.88M |
| Short Term Debt | Q2 2025 · Sep 30, 2024 | $13.32M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $2M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $6.56M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $12.95M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $13.19M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $18.98M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $20.18M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $19M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $20.18M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $21.58M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $20.83M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $34.71M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $36.25M |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | $0.01 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.02 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | $0.01 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.02 |
| Sga Expense | Q2 2025 · Mar 31, 2025 | $1.87M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $777.06K |
| Rd Expense | Q2 2025 · Mar 31, 2025 | $253.08K |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $178.78K |
| Net Income | Q2 2025 · Mar 31, 2025 | $13.16K |
| Net Income | Q2 2025 · Mar 31, 2024 | $226.53K |
| Gross Profit | Q2 2025 · Mar 31, 2025 | $1.56M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $1.54M |
| Revenue | Q2 2025 · Mar 31, 2025 | $4.54M |
| Revenue | Q2 2025 · Mar 31, 2024 | $5.31M |